FDA assigned PDUFA target action date of July 7, 2026. If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN. Atacicept received FDA Breakthrough Therapy ...
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...
The city's controversial installation of transit priority lanes on Bathurst St. and Dufferin St. is showing wear and tear just weeks after they were installed. The city says the cost will be covered ...
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #FDA--Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and ...
The Provisioner spacecraft by Astroscale U.S. will refuel two Space Force spacecraft on a mission scheduled to launch in the summer of 2026. Credit: Astroscale U.S. ORLANDO, Fla. — Government and ...
This study proposes a novel approach to the Vehicle Routing Problem with Task Priority and Limited Resources (VRPTPLR) by leveraging a Graph Neural Network (GNN) encoder. Unlike conventional methods ...
WASHINGTON (AP) — The Trump administration has instructed U.S. embassies and consulates around the world to prioritize visa applications from foreigners wishing to visit the United States to either ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s New Drug Application (NDA) for baxdrostat has been accepted for Priority Review by the US Food and Drug Administration (FDA) in the US for the ...
Submission based on positive BaxHTN Phase III trial results which demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with resistant or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback